BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
2.035
+0.005 (0.25%)
Sep 4, 2026, 11:17 AM EDT - Market open

BioVie Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
1515172415636
Market Cap Growth
33.47%-14.70%-29.93%-84.35%331.64%-90.43%
Enterprise Value
72-6312623
Last Close Price
2.031.949.2540.05431.00145.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PB Ratio
1.491.430.901.5810.199.87
P/TBV Ratio
1.541.470.931.6610.8914.73

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.030.030.020.390.943.34
Net Debt / Equity Ratio
-0.85-0.85-0.90-1.14-1.27-1.74
Net Debt / EBITDA Ratio
0.390.390.960.560.440.24
Quick Ratio
2.932.938.642.552.344.47
Current Ratio
3.593.599.102.572.354.50
Return on Equity (ROE)
-150.76%-150.76%-101.64%-208.26%-528.70%-598.18%
Return on Assets (ROA)
-79.06%-79.06%-48.28%-66.69%-102.05%-130.22%
Return on Capital Employed (ROCE)
-216.70%-216.70%-93.70%-202.90%-218.70%-170.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-144.44%-150.86%-102.28%-131.23%-32.14%-72.00%
Buyback Yield / Dilution
-390.46%-390.46%-226.96%-39.10%-31.71%-98.84%
SEC Filings: 10-K · 10-Q